Marcin Frąckiewicz

Marcin Frąckiewicz is the founder and CEO of TS2 Space, a satellite communications company serving customers around the world. A graduate of the Warsaw School of Economics (SGH), he has more than two decades of experience in telecommunications, satellite services and technology ventures. He writes about satellite communications, space technology, artificial intelligence and the stock market, with a particular focus on technology companies, semiconductors, emerging industries and the trends shaping global innovation. Follow Marcin Frąckiewicz on Google News, Facebook. or Linkedin.

Gold Soars Past $4,000 for the First Time – Inside the Historic Rally and What’s Next

Gold Price Today, 9 Nov 2025: XAU/USD holds near $4,000 ahead of U.S. CPI; India retail rates mixed

With spot markets shut on Sunday, traders are working off Friday’s close and weekend dealer indications. Reuters reported spot gold around $4,005/oz late Friday, while December COMEX settled at $4,009.80/oz. Investing.com’s daily table shows a $3,999.72/oz close, high $4,027.63, low $3,974.41. Early Sunday dealer quotes were still clustered just above $4,000/oz. Reuters+2Investing.com+2
9 November 2025
Ondas Holdings Skyrockets into the U.S. Defense Drone Race – Is ONDS the Next Tech Titan?

Ondas Holdings (ONDS) Jumps as Lock‑Up Expires; Zacks Names ‘Bull of the Day’ and Fresh Fund Buying Sets the Stage Ahead of Nov. 13 Earnings

Summary: Ondas Holdings Inc. capped the week with a sharp Friday rally and a burst of coverage and flow‑of‑funds headlines. A 60‑day lock‑up tied to recent financing expired on Saturday, Nov. 8, while Zacks highlighted the company as its “Bull of the Day” on Friday. Options markets are pricing a double‑digit swing into Thursday’s Q3 report, and at least one wealth manager disclosed a new ONDS stake. Below is everything that moved the story between Nov. 7–8, 2025. Ondas Holdings Inc.
Pfizer (PFE) Clinches $10B Metsera Deal, Beating Novo Nordisk — What the Winning Bid Means for the Obesity-Drug Race (Nov. 8, 2025)

Pfizer (PFE) Clinches $10 Billion Metsera Deal as Novo Nordisk Exits—What It Means for the Obesity Drug Race (Nov. 8, 2025)

Late Friday, Metsera accepted a sweetened offer from Pfizer: $65.60 per share in cash plus a contingent value right of up to $20.65 per share, valuing the biotech at up to $10 billion. On Saturday, Novo Nordisk said it would not increase its bid and exited the race, citing legal and regulatory risks tied to its two‑step proposal. Metsera’s board said Pfizer’s amended agreement carries lower antitrust risk and recommended shareholders approve it at a Nov. 13 meeting. PR Newswire+1
Breaking: Eos Energy & MN8 Secure Huge 750 MWh U.S. Battery Storage Deal – Are Stocks Set to Skyrocket?

Eos Energy (EOSE) News Today: Price Target Uplift, Fresh Downgrade, and 70% Warrant Surge — What’s Moving the Stock (Nov 8, 2025)

Downgrade lands after the run-up. MarketBeat carried an alert that Wall Street Zen cut EOSE to “Sell” early Saturday, noting the stock’s sharp appreciation and summarizing the existing split in coverage. While not a bulge-bracket call, the downgrade adds a counterweight to bullish revisions that followed earnings. MarketBeat
8 November 2025
Qualys (QLYS) News Roundup for Nov. 7–8, 2025: Analyst Upgrade, EPS Estimate Lift, and Stock Holds Near $150 After Q3 Beat

Qualys (QLYS) News Roundup for Nov. 7–8, 2025: Analyst Upgrade, EPS Estimate Lift, and Stock Holds Near $150 After Q3 Beat

Dateline: November 8, 2025 — Cybersecurity vendor Qualys, Inc. stayed in the headlines heading into the weekend, with fresh analyst reactions following Tuesday’s earnings beat, a state pension fund disclosing a larger stake, and continued chatter around its agentic‑AI roadmap. Below is a concise, Google News–ready digest of everything new about Qualys published November 7–8, 2025.
8 November 2025
Samsung Galaxy S26 Leak Explosion: Massive Camera Upgrades, Thinner Designs & a Shocking S Pen Twist

‘Landfall’ spyware abused Samsung zero‑day (CVE‑2025‑21042) to hack Galaxy phones for months — patched in April: What happened and how to stay safe

Security researchers have uncovered a previously unknown, commercial‑grade Android spyware operation—dubbed Landfall—that exploited a zero‑day flaw in Samsung Galaxy phones and ran largely undetected for close to a year, with targets concentrated in parts of the Middle East. Samsung fixed the underlying vulnerability in an April 2025 firmware update, but the campaign and its methods are only now coming to light. TechCrunch+1
8 November 2025
Android Auto gets Gemini today (Nov 7, 2025): Live support begins rolling out, what’s new in v15.4, and what’s coming next

Android Auto gets Gemini today (Nov 7, 2025): Live support begins rolling out, what’s new in v15.4, and what’s coming next

After months of hints, Google’s Gemini is now turning on inside Android Auto for some users as of today. The activation is server‑side, so there’s no single app update that guarantees it; however, many of the first reports come from devices running Android Auto 15.6 or 15.7. Once enabled, Gemini replaces Google Assistant entirely in the car but still responds to “Hey Google.” 9to5Google+2Android Authority+2
Samsung Galaxy S27 Ultra may debut ‘Polar ID’ polarized‑light face unlock without IR hardware

Samsung Galaxy S27 Ultra may debut ‘Polar ID’ polarized‑light face unlock without IR hardware

Early test firmware references suggest Samsung is exploring a new facial authentication system called Polar ID for the Galaxy S27 Ultra. The tech reportedly uses polarized light instead of a dedicated IR dot projector, targets ~180 ms unlock times, ties into an ISOCELL Vizion front sensor and a new “BIO‑Fusion Core” secure enclave routine, and is aimed at improving spoof resistance over today’s 2D face unlock. The S27 Ultra itself isn’t expected until early 2027, and Samsung has not confirmed any of this—so treat it as an informed rumor for now. Wccftech
8 November 2025
MIT reports nodal, unconventional superconductivity in magic‑angle graphene — Nov. 7, 2025

MIT reports nodal, unconventional superconductivity in magic‑angle graphene — Nov. 7, 2025

MIT physicists have presented the clearest evidence so far that magic‑angle twisted trilayer graphene hosts unconventional, nodal superconductivity. The results, published in Science on November 6, show a distinctive V‑shaped superconducting gap—a hallmark of non‑BCS pairing—captured with a custom platform that combines tunneling spectroscopy and transport on an all–van der Waals stack. MIT News+2EurekAlert!+2
8 November 2025
Sharper Black Hole Images Could Put Einstein’s Gravity to the Test: New Study Maps What Future Telescopes Must See (7 Nov 2025)

Sharper Black Hole Images Could Put Einstein’s Gravity to the Test: New Study Maps What Future Telescopes Must See (7 Nov 2025)

A wave of coverage on Friday highlighted a new Nature Astronomy study that sets a concrete target for the next generation of black hole images: if upcoming telescopes can reach percent‑level fidelity, they could tell Einstein’s black holes apart from a range of look‑alikes predicted by alternative theories of gravity. The paper—published November 5—uses advanced simulations to show that when the mismatch between images exceeds roughly 2–5%, future instruments should be able to rule out many non‑Einstein models. Nature
8 November 2025
Blue Origin to Launch NASA’s Twin ESCAPADE Mars Probes on Nov. 9: Time, Livestream, Mission Goals, and What Happens Next

Blue Origin to Launch NASA’s Twin ESCAPADE Mars Probes on Nov. 9: Time, Livestream, Mission Goals, and What Happens Next

Blue Origin’s New Glenn is slated to lift off Nov. 9 carrying ESCAPADE—Escape and Plasma Acceleration and Dynamics Explorers—two identical NASA satellites designed to explain how Mars lost most of its atmosphere and water. The probes will make coordinated measurements to build a 3D, time‑varying picture of Mars’ upper atmosphere and magnetic environment, something a single spacecraft can’t do. It’s NASA’s first dual‑satellite mission to another planet, marking a milestone for low‑cost planetary science. Space
8 November 2025
Stocks Slip as Tech Wobble Returns; Layoffs Spike and Tariff Showdown Clouds Outlook — Stock Market Today (Nov. 6, 2025)

Nasdaq Posts Worst Week Since April as AI Selloff Deepens; Mixed Close on Nov. 7 After Tech-Led Rout Nov. 6, Jobs Data Blackout Weighs on Sentiment

Summary: Wall Street ended Friday mixed after a bruising tech-driven downdraft on Thursday. The Nasdaq logged its steepest weekly drop since April as investors questioned AI valuations, while a historic U.S. government shutdown erased key economic releases for a second month—forcing traders to lean on private labor gauges. Tesla’s shareholder approval of Elon Musk’s record $1 trillion pay package added a headline-grabbing twist to a volatile two-day stretch. Reuters+3Reuters+3Reuters+3
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 08.11.2025

{“@context”:”https://schema.org”,”@type “:”LiveBlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-08-11-2025/#live”,”headline”:”Stock Market Today 08.11.2025″,”description”:”Live rolling coverage of technology news: AI, chips, gadgets, software, startups, cybersecurity, telecom, and policy.”,”datePublished”:”2025-11-08T00:00:00-05:00″,”dateModified”:”2025-11-09T00:00:03-05:00″,”coverageStartTime”:”2025-11-08T00:00:00-05:00″,”coverageEndTime”:”2025-11-09T00:00:03-05:00″,”author”:{“@type”:”Organization”,”name”:”TechStock²”},”publisher”:{“@type”:”Organization”,”name”:”TechStock²”,”logo”:{“@type”:”ImageObject”,”url”:”https://ts2.tech/wp-content/uploads/2024/02/cropped-ts2-logo-google.png”}},”inLanguage”:”en-US”,”liveBlogUpdate”:[{“@type”:”BlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-08-11-2025/#live/u/2314de997ba25bfa”,”headline”:”National Health Investors Valuation Check: Is NHI Still Undervalued After Momentum?”,”articleBody”:”National Health Investors (NHI) has advanced about 4% in the last month, yielding a three-year total return near 60% while the one-year return remains flat, signaling mixed sentiment. With shares at $76.80 and a fair value call of $83.14, a valuation gap persists that could pave upside if SHOP expansion drives earnings. The note highlights potential for outsized multi-year NOI and earnings growth, but warns that near-term risks include occupancy softness and
8 November 2025
1 221 222 223 224 225 409

Stock Market Today

  • Revolution Medicines (RVMD) Shares Trade at a Premium Despite Robust Gains
    July 25, 2026, 2:47 PM EDT. Revolution Medicines (RVMD) shares have jumped with a 399.2% return over the past year and approximately 6.4x growth in three years, though the stock's valuation is considered steep. With a P/B ratio of 26.8x, Revolution Medicines is well above the Biotech sector's 2.5x average and peer level of 10.3x. The stock meets just 2 out of 6 valuation criteria, indicating a premium linked to its FDA-reviewed drug daraxonrasib and data from its pancreatic cancer trial, along with concerns tied to regulatory risk.